Olon

  With our biggest satisfaction, Olon has received Industria Felix Award, one of the main Italian recognition to business excellence. Industria Felix rewards the best companies in Italy. A high financial honor, assigned according to objective requirements to the best performing companies looking at management standards, financial reliability, sustainability, growth, and development. Italian Minister of Enterprises and Made in Italy Adolfo Urso declared «This quality recognition to the best companies is a guarantee of excellent work. We need to look at companies not only as a lever for economic development, but also as a tool for achieving fairer growth in environmental and collective terms» Alfio Mason #development #growth #leadership

🎤 🔊 💚 🌍 Thanks to CHEManager for the great article reporting our progresses in sustainability focus area! See the article here : https://lnkd.in/dRH35--u

#Olon announces a further milestone of investment in its #manufacturing plant located in India, the VI Mod-6 project. It has increased the production capacity of the site of about 25%. This state-of-the-art facility is designed to run #cryogenic reactions and hazardous nBuLi reactions at large scale, both with high safety and environmental standards and high technical performance. New equipment purchasing, engineering development, installation works, commissioning, and final qualification have been completed. The facility was successfully qualified in September 2024 #activepharmaceuticalingredients #API #pharmasupplychain

💚 💚 🌍 🌎 From 2020 to 2023 we have progressively reduced the water consumption per ton of manufactured products with a significant reduction of #Olon #environmental #footprint see the numbers here or go through our full Company ESG Report here https://lnkd.in/dqrHhVJb

💚 💚 🌍 🌎 From 2020 to 2023 we have progressively reduced the total waste per ton of manufactured products. The facts outline a significant reduction of Olon #environmental #footprint see the numbers here or go through Company ESG Report here https://lnkd.in/dqrHhVJb

💚 💚 From 2018 to 2023, Olon has overall reduced CO2 emissions by 60%, energy consumption per ton of product by 60%, water consumption by 60%, waste generated by 40%, and increased the waste recycling rate by 50% Against the backdrop of the early achievement of the 2018 / 2025 targets, we set new long-term environmental targets. Our new environmental targets have been published in the new ESG corporate report here https://lnkd.in/dchf_kMd

We are expanding the product portfolio to include additional therapies in high value areas Olon has outlined its development and consolidation strategy in the API market, driven by the recent acquisition of HuvePharma Italia and the production site in Garessio, Italy. The recently acquired manufacturing plant brings extensive expertise in API development and production, complemented by a strong track record in adopting and integrating cutting-edge technologies. With its production lines fully automated, the facility has advanced the production of a critical antimalarial treatment, semi-synthetic artemisinin, using innovative photo-oxidation technology and nanoparticle manufacturing. By ensuring a stable and resilient supply chain for artemisinin, the plant plays a pivotal role in safeguarding access to affordable ACTs, which save millions of lives annually. This dedication underscores the commitment to delivering life-saving therapies to those who need them most Read the full story here https://lnkd.in/dCbSjY_D

Olon releases its annual ESG report thanks to the magazine @Manufacturing Chemist for the story see here https://lnkd.in/dYRap66e

#CPHI India is back! #Olon will be attending 2024 edition, meet us at our stand 1.C19, from November 26 to 28

#Manufacturing #Chemist Stand Side with Olon 📽 Watch the just released video interviews to our CEO Paolo Tubertini and VP Olon #Biotech Maurizio Sartorato to get an insight about the values and purposes of the recent acquisitions finalized by #Olon Group "With GTP Bioways we integrate highly specialized services. Now we have the capabilities to supply full services to support R&D, development, full scale production phases. Moreover, the technology of mammalian production" Maurizio Sartorato comments https://lnkd.in/dhsrkVfM.